MONTE ROSA THERAPEUTICS INC (GLUE) Top Institutional Shareholders
MONTE ROSA THERAPEUTICS INC (GLUE) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $1.31B in GLUE holdings during the latest filing period.
Nea Management Company, Llc is currently the largest disclosed institutional shareholder of GLUE tracked by InsiderSet, reporting ownership valued at approximately $126.54M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $141.62M, representing an estimated gain of +11.91% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 56% of the total disclosed GLUE value among the investors covered in this analysis. Major shareholders include Nea Management Company, Llc, Blackrock, Inc., Tcg Crossover Management, Llc, and several other long-term asset managers with concentrated positions in MONTE ROSA THERAPEUTICS INC (GLUE).
This page ranks the largest institutional GLUE shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
186
Total Reported Value
$1.31B
Largest Holder
Nea Management Company, Llc
Largest Position
$126.54M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
174
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Nea Management Company, Llc | 7.19% | 7,692,298 | $126,538,302 | $141,615,206 | +$15,076,904 | +11.91% | |
| Blackrock, Inc. | 0.00% | 5,637,684 | $92,739,901 | $103,789,762 | +$11,049,861 | +11.91% | |
| Tcg Crossover Management, Llc | 2.18% | 4,622,151 | $76,034,384 | $85,093,800 | +$9,059,416 | +11.91% | |
| Bvf Inc/Il | 2.34% | 4,460,886 | $73,381,575 | $82,124,911 | +$8,743,336 | +11.91% | |
| Baker Bros. Advisors Lp | 0.41% | 4,345,736 | $71,487,357 | $80,005,000 | +$8,517,643 | +11.91% | |
| Suvretta Capital Management, Llc | 1.89% | 4,226,809 | $69,531,008 | $77,815,554 | +$8,284,546 | +11.91% | |
| Vestal Point Capital, Lp | 1.66% | 3,603,465 | $59,276,999 | $66,339,791 | +$7,062,792 | +11.91% | |
| State Street Corp | 0.00% | 3,353,980 | $55,172,971 | $61,746,772 | +$6,573,801 | +11.91% | |
| Braidwell Lp | 1.76% | 3,206,574 | $52,748,142 | $59,033,027 | +$6,284,885 | +11.91% | |
| Versant Venture Management, Llc | 37.00% | 3,180,780 | $52,323,831 | $58,558,160 | +$6,234,329 | +11.91% | |
| Vanguard Capital Management Llc | 0.00% | 3,100,245 | $50,999,030 | $57,075,510 | +$6,076,480 | +11.91% | |
| American Century Companies Inc | 0.02% | 2,809,647 | $46,218,693 | $51,725,601 | +$5,506,908 | +11.91% | |
| Silverarc Capital Management, Llc | 3.88% | 2,002,040 | $32,933,558 | $36,857,556 | +$3,923,998 | +11.91% | |
| Aisling Capital Management Lp | 5.37% | 1,555,664 | $25,590,673 | $28,639,774 | +$3,049,101 | +11.91% | |
| Geode Capital Management, Llc | 0.00% | 1,540,812 | $25,352,784 | $28,366,349 | +$3,013,565 | +11.89% | |
| Marshall Wace, Llp | 0.03% | 1,433,152 | $23,575,351 | $26,384,328 | +$2,808,977 | +11.91% | |
| Bellevue Group Ag | 0.49% | 1,250,000 | $20,562,500 | $23,012,500 | +$2,450,000 | +11.91% | |
| Mpm Bioimpact Llc | 1.50% | 1,176,928 | $19,360,466 | $21,667,244 | +$2,306,778 | +11.91% | |
| Dimensional Fund Advisors Lp | 0.00% | 1,041,372 | $17,124,824 | $19,171,659 | +$2,046,835 | +11.95% | |
| Fmr Llc | 0.00% | 1,024,304 | $16,849,800 | $18,857,437 | +$2,007,637 | +11.91% | |
| Goldman Sachs Group Inc | 0.00% | 1,001,527 | $16,475,119 | $18,438,112 | +$1,962,993 | +11.91% | |
| Frazier Life Sciences Management, L.P. | 0.42% | 1,000,000 | $16,450,000 | $18,410,000 | +$1,960,000 | +11.91% | |
| Northern Trust Corp | 0.00% | 826,624 | $13,597,964 | $15,218,148 | +$1,620,184 | +11.91% | |
| Janus Henderson Group Plc | 0.01% | 685,926 | $11,293,772 | $12,627,898 | +$1,334,126 | +11.81% | |
| Alphabet Inc. | 0.28% | 684,275 | $11,256,324 | $12,597,503 | +$1,341,179 | +11.91% | |
| Morgan Stanley | 0.00% | 684,063 | $11,252,836 | $12,593,600 | +$1,340,764 | +11.91% | |
| Aqr Capital Management Llc | 0.00% | 658,483 | $10,832,046 | $12,122,672 | +$1,290,626 | +11.91% | |
| Nantahala Capital Management, Llc | 0.67% | 651,993 | $10,725,285 | $12,003,191 | +$1,277,906 | +11.91% | |
| Arrowstreet Capital, Limited Partnership | 0.01% | 647,739 | $10,655,307 | $11,924,875 | +$1,269,568 | +11.91% | |
| Charles Schwab Investment Management Inc | 0.00% | 546,689 | $8,993,034 | $10,064,544 | +$1,071,510 | +11.91% | |
| Bridgeway Capital Management, Llc | 0.17% | 528,698 | $8,697,082 | $9,733,330 | +$1,036,248 | +11.91% | |
| Vanguard Portfolio Management Llc | 0.00% | 515,966 | $8,487,641 | $9,498,934 | +$1,011,293 | +11.91% | |
| Vanguard Fiduciary Trust Co | 0.00% | 407,078 | $6,696,433 | $7,494,306 | +$797,873 | +11.91% | |
| Cormorant Asset Management, Lp | 0.33% | 400,000 | $6,580,000 | $7,364,000 | +$784,000 | +11.91% | |
| Allspring Global Investments Holdings, Llc | 0.01% | 392,227 | $6,452,134 | $7,220,899 | +$768,765 | +11.91% | |
| Bank Of America Corp | 0.00% | 387,542 | $6,375,066 | $7,134,648 | +$759,582 | +11.91% | |
| Renaissance Technologies LLC | Jim Simons | 0.01% | 379,100 | $6,236,195 | $6,979,231 | +$743,036 | +11.91% |
| Fisher Asset Management, Llc | 0.00% | 314,862 | $5,179,479 | $5,796,609 | +$617,130 | +11.91% | |
| Empowered Funds, Llc | 0.03% | 305,398 | $5,023,797 | $5,622,377 | +$598,580 | +11.91% | |
| Nextech Invest, Ltd. | 0.35% | 304,237 | $5,004,699 | $5,601,003 | +$596,304 | +11.91% | |
| Td Asset Management Inc | 0.00% | 286,978 | $4,720,788 | $5,283,265 | +$562,477 | +11.91% | |
| Balyasny Asset Management L.P. | 0.01% | 256,731 | $4,223,225 | $4,726,418 | +$503,193 | +11.91% | |
| Citadel Advisors Llc | 0.00% | 254,518 | $4,186,821 | $4,685,676 | +$498,855 | +11.91% | |
| Adage Capital Partners Gp, L.L.C. | 0.01% | 250,000 | $4,112,500 | $4,602,500 | +$490,000 | +11.91% | |
| Adar1 Capital Management, Llc | 0.21% | 215,752 | $3,549,120 | $3,971,994 | +$422,874 | +11.91% | |
| Manufacturers Life Insurance Company, The | 0.00% | 209,801 | $3,451,226 | $3,862,436 | +$411,210 | +11.91% | |
| Bank Of New York Mellon Corp | 0.00% | 204,687 | $3,367,104 | $3,768,288 | +$401,184 | +11.91% | |
| Nomura Asset Management International Inc. | 0.01% | 200,000 | $3,290,000 | $3,682,000 | +$392,000 | +11.91% | |
| Franklin Resources Inc | 0.00% | 199,722 | $3,285,427 | $3,676,882 | +$391,455 | +11.91% | |
| Atom Investors Lp | 0.23% | 194,476 | $3,199,130 | $3,580,303 | +$381,173 | +11.91% |
Frequently asked questions about GLUE
Who owns the most GLUE stock?
The largest holders of GLUE are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for MONTE ROSA THERAPEUTICS INC (GLUE).
Is GLUE widely held by superinvestors?
Many widely followed stocks like GLUE appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly GLUE is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.